{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:52:08Z","timestamp":1787863928607,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantova agentura Ceske republiky","doi-asserted-by":"publisher","award":["22-14961S"],"award-info":[{"award-number":["22-14961S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2026.120704","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:55:34Z","timestamp":1773334534000},"page":"120704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Soluble endoglin as a biomarker of cardiovascular and metabolic disorders related to endothelial dysfunction: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"415","author":[{"given":"Jana","family":"Urbankova Rathouska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Emadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Nemeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Fikrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Tripska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-1444","authenticated-orcid":false,"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-7295","authenticated-orcid":false,"given":"Petr","family":"Nachtigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120704_bib1","doi-asserted-by":"crossref","first-page":"H959","DOI":"10.1152\/ajpheart.01251.2009","article-title":"The physiological role of endoglin in the cardiovascular system","volume":"299","author":"Lopez-Novoa","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120704_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120704_bib3","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-09-4466","article-title":"Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis","volume":"70","author":"Hawinkels","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120704_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123107","article-title":"MMP-12, secreted by pro-inflammatory macrophages, targets endoglin in human macrophages and endothelial cells","volume":"20","author":"Aristorena","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s42003-025-07751-3","article-title":"Thrombin cleaves membrane-bound endoglin potentially contributing to the heterogeneity of circulating endoglin in preeclampsia","volume":"8","author":"El Hamaoui","year":"2025","journal-title":"Commun Biol"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.120704_bib6","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/j.cell.2024.07.012","article-title":"A systems view of the vascular endothelium in health and disease","volume":"187","author":"Augustin","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10753-023-01911-5","article-title":"SIRT6 protects against lipopolysaccharide-induced inflammation in human pulmonary lung microvascular endothelial cells","volume":"47","author":"Wang","year":"2024","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00018-025-05828-0","article-title":"Microtubules and mechanosensing: key players in endothelial responses to mechanical stimuli","volume":"82","author":"Mohammed","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120704_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115108","article-title":"Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: novel opportunities for primary prevention","volume":"202","author":"Benincasa","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120704_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101622","article-title":"Global cardiovascular diseases death rate prediction","volume":"48","author":"Gaidai","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120704_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ehjqcco\/qcae090","article-title":"Burden of cardiovascular disease attributable to metabolic risks in 204 countries and territories from 1990 to 2021","volume":"11","author":"Chen","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120704_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tcm.2015.03.005","article-title":"A reliable marker of vascular function: does it exist?","volume":"25","author":"Blann","year":"2015","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120704_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel biomarkers for evaluation of endothelial dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120704_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2015.10.003","article-title":"Soluble endoglin, hypercholesterolemia and endothelial dysfunction","volume":"243","author":"Rathouska","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120704_bib15","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-020-03701-w","article-title":"Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome","volume":"78","author":"Vicen","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120704_bib16","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1582-4934.2008.00156.x","article-title":"Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction","volume":"12","author":"Cruz-Gonzalez","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.atherosclerosis.2026.120704_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2017.12.040","article-title":"Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke","volume":"478","author":"He","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120704_bib19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.amjcard.2010.08.018","article-title":"Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure","volume":"106","author":"Kapur","year":"2010","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120704_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12889-025-25883-3","article-title":"Impact of artificial light at night on obesity and overweight: a systematic review and meta-analysis","volume":"26","author":"Tang","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.atherosclerosis.2026.120704_bib22","series-title":"Comprehensive meta-analysis","author":"Borenstein","year":"2005"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120704_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1515\/jpem-2020-0146","article-title":"The relation of serum endocan and soluble endoglin levels with metabolic control in children and adolescents with type 1 diabetes mellitus","volume":"33","author":"Anik","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1-2","key":"10.1016\/j.atherosclerosis.2026.120704_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(95)05713-7","article-title":"Serum levels of the TGF-Beta receptor are increased in atherosclerosis","volume":"120","author":"Blann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120704_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1741-7015-8-86","article-title":"Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients","volume":"8","author":"Blazquez-Medela","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120704_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ22-0550","article-title":"Increased soluble endoglin levels in newly-diagnosed type 2 diabetic patients are associated with endothelial dysfunction","volume":"70","author":"Dou","year":"2023","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5114\/aoms.2018.79488","article-title":"Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus","volume":"15","author":"Ekiz-Bilir","year":"2019","journal-title":"Arch Med Sci"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4274\/jcrpe.2906","article-title":"Soluble endoglin level increase occurs prior to development of subclinical structural vascular alterations in diabetic adolescents","volume":"8","author":"Emeksiz","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120704_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/clc.20979","article-title":"Endothelial function and soluble endoglin in smokers with heart failure","volume":"34","author":"Heffernan","year":"2011","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120704_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4274\/jcrpe.galenos.2020.2020.0134","article-title":"Association of exosomal miR-34a with markers of dyslipidemia and endothelial dysfunction in children and adolescents with T1DM","volume":"12","author":"Ibrahim","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120704_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/2045-8932.110445","article-title":"Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension","volume":"3","author":"Malhotra","year":"2013","journal-title":"Pulm Circ"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1582-4934.2005.tb00499.x","article-title":"Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy","volume":"9","author":"Malik","year":"2005","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120704_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cbf.2987","article-title":"Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy","volume":"32","author":"Motawi","year":"2014","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120704_bib35","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.7150\/ijms.115222","article-title":"Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study","volume":"22","author":"Rathouska","year":"2025","journal-title":"Int J Med Sci"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120704_bib36","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-020-03701-w","article-title":"Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome","volume":"78","author":"Vicen","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166990","article-title":"Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo","volume":"1870","author":"Eissazadeh","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120704_bib38","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/endo.134.6.8194490","article-title":"Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells","volume":"134","author":"St-Jacques","year":"1994","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120704_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090997","article-title":"Endoglin trafficking\/exosomal targeting in liver cells depends on N-Glycosylation","volume":"8","author":"Meurer","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120704_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/eji.1830220216","article-title":"Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen","volume":"22","author":"Lastres","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.120704_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123428","article-title":"Anti-endoglin monoclonal antibody prevents the progression of liver sinusoidal endothelial inflammation and fibrosis in MASH","volume":"364","author":"Eissazadeh","year":"2025","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120704_bib42","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1096\/fj.201802245R","article-title":"Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro","volume":"33","author":"Vicen","year":"2019","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120704_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/14737159.2024.2391021","article-title":"Serum biomarkers for predicting microvascular complications of diabetes mellitus","volume":"24","author":"Wang","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.26444\/aaem\/76937","article-title":"Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis","volume":"24","author":"Prystupa","year":"2017","journal-title":"Ann Agric Environ Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120704_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.crd.0000249381.49138.b9","article-title":"Pulmonary artery hypertension: Caveolin-1 and eNOS interrelationship: a new perspective","volume":"15","author":"Mathew","year":"2007","journal-title":"Cardiol Rev"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120704_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.phrs.2011.03.008","article-title":"Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis","volume":"64","author":"Rathouska","year":"2011","journal-title":"Pharmacol Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:40:04Z","timestamp":1779252004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S0021915026000705"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120704","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble endoglin as a biomarker of cardiovascular and metabolic disorders related to endothelial dysfunction: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120704"}}